Fostamatinib for severe breathing failure in hospitalized adults
Treatments studied
Part of Lungs & breathing clinical trials.
This trial tests a drug called fostamatinib to see if it can help people with a severe lung condition called ARDS, which causes breathing failure. If you are in the hospital on a breathing machine, this drug might help your lungs recover.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are in the hospital with severe breathing failure (ARDS) and are on a breathing machine (ventilator) or a heart-lung machine.
- You have had a CT scan of your chest in the last 7 days.
- You have been on the breathing machine for less than 10 days.
- You are not pregnant, not breastfeeding, and if you could become pregnant, you agree to use effective birth control during the study and for 30 days after.
- You do not have severe liver disease or abnormal liver tests, and you do not have uncontrolled high blood pressure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing new treatments for people with ARDS, a serious lung condition. The goal is to find therapies that help patients breathe better and recover faster. If you or a loved one has ARDS, this study may offer access to experimental treatments.
This trial tests a new medicine (LEAF-4L6715) for people with acute respiratory distress syndrome (ARDS), a serious lung condition. The aim is to see if this medicine helps improve breathing and recovery in people on a breathing machine. The trial is for adults who have had ARDS for at least 24 hours and are already on a breathing machine.
This trial tests a new treatment using stem cells from umbilical cords, given through an IV, for people with severe ARDS. The goal is to see if it's safe and helps improve breathing.
This trial tests if bevacizumab can help people with ARDS (a serious lung condition) breathe better. It is for patients with mild, moderate, or severe ARDS who are already in the hospital.
This Phase 3 trial studies an “extracellular vesicle” treatment in people with moderate to severe ARDS, a serious lung breathing problem. The goal is to see whether the treatment can improve outcomes compared with standard care.
This trial tests a new medicine called fostamatinib for people who have had a lung transplant and have developed donor-specific antibodies (DSA) on their lung. The goal is to see if this medicine is safe and can help prevent the body from rejecting the new lung.
Hear when a new Acute Respiratory Distress Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.